Latest Insights on DNA
Genes Get Wilder: 23andMe, You & Big Brother
June 19, 2021 Great Stuff
What’s The Deal With 23andMe? Great Ones, what do you know about 23andMe (Nasdaq: )? Some of you probably know 23andMe from its home testing kits. No, not home drug tests — genetic tests that tell you where your ancestors came from. 23andMe’s tests were a popular holiday/birthday gift a few years ago. According to […] Nvidia ARM Wrestles U.K., AMD Scores With Google & Trade Desk Decimated
June 18, 2021 Great Stuff
Friday Four Play: The “AnARMchy In The U.K.” Edition Great Ones, have you checked in on your Nvidia (Nasdaq: ) position lately? What Nvidia position? You know, the one I recommended not three weeks ago in Great Stuff’s weekend edition: “What’s The Deal With Nvidia?” I made it an official Great Stuff Picks recommendation too. […] New Biotech SPACs Could Help Spark a Rally
June 8, 2021 Investment Opportunities, Technology, Winning Investor Daily
One venture capitalist’s decision to specifically target biotech companies suggests the industry presents the highest return potential. You Can Save Lives and Profit by Investing in This Mega Trend
May 5, 2021 American Investor Today, Investment Opportunities, Technology
(4-minute read) You don’t need to be a molecular biologist to understand this technology. It not only saves lives, it could also hand you profits in the years ahead… Old Man Yells At Bitcoin, Verizon’s Yard Sale & Tesla Battles The Bulge
May 3, 2021 Great Stuff
Berkshire’s Munger Strike Berkshire Hathaway (NYSE: ) had a shareholders meeting this weekend. And we should care because? Agreed. No one cares about Berkshire events. I mean, the stock trades north of $420,000 per share. Do you own BRK.A? If so, why are you reading me? Am I that entertaining? (I hope so.) Anyway, Berkshire […]